Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Douglas Middleton Dahl, M.D.

Co-Author

This page shows the publications co-authored by Douglas Dahl and Scott McDougal.
Connection Strength

0.674
  1. A prospective study of symptom distress and return to baseline function after open versus laparoscopic radical prostatectomy. J Urol. 2009 Sep; 182(3):956-65.
    View in: PubMed
    Score: 0.413
  2. Pathologic outcome of laparoscopic and open radical prostatectomy. Urology. 2006 Dec; 68(6):1253-6.
    View in: PubMed
    Score: 0.086
  3. Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years. Urol Oncol. 2015 Sep; 33(9):383.e9-16.
    View in: PubMed
    Score: 0.039
  4. A close surgical margin after radical prostatectomy is an independent predictor of recurrence. J Urol. 2012 Jul; 188(1):91-7.
    View in: PubMed
    Score: 0.031
  5. Case records of the Massachusetts General Hospital. Case 9-2012. A 67-year-old man with a persistently elevated PSA level. N Engl J Med. 2012 Mar 22; 366(12):1143-50.
    View in: PubMed
    Score: 0.031
  6. Smaller prostate gland size and older age predict Gleason score upgrading. Urol Oncol. 2013 Oct; 31(7):1033-7.
    View in: PubMed
    Score: 0.031
  7. Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology. 2008 Apr; 71(4):708-12.
    View in: PubMed
    Score: 0.023
  8. A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: a new method for noninvasive lymph node evaluation. Urology. 2005 Nov; 66(5):1066-71.
    View in: PubMed
    Score: 0.020
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.